Anti-TIGIT to overcome resistance to immune checkpoint inhibitors in lung cancer: limits and potentials. Attili I, Passaro A, de Marinis F. Ann Oncol 2021 Nov 25. pii: S0923-7534(21)04823.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Attili I, Passaro A, de Marinis F. Anti-TIGIT to overcome resistance to immune checkpoint inhibitors in lung cancer: limits and potentials. Ann Oncol 2021 Nov 25. pii: S0923-7534(21)04823.
PMID: 34839015